| 1.0 |
2.9 |
GO:0014707 |
branchiomeric skeletal muscle development(GO:0014707) |
| 0.9 |
4.5 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.5 |
2.9 |
GO:2000721 |
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.4 |
2.7 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.4 |
1.3 |
GO:0031104 |
dendrite regeneration(GO:0031104) |
| 0.4 |
1.2 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.4 |
1.1 |
GO:0060458 |
right lung development(GO:0060458) |
| 0.4 |
0.4 |
GO:0035801 |
adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) |
| 0.3 |
1.9 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.3 |
1.5 |
GO:0072204 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.3 |
1.9 |
GO:0086048 |
membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.3 |
2.3 |
GO:0035502 |
metanephric part of ureteric bud development(GO:0035502) |
| 0.3 |
1.0 |
GO:0010645 |
regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
| 0.2 |
0.7 |
GO:0060722 |
spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.2 |
2.7 |
GO:0038044 |
transforming growth factor-beta secretion(GO:0038044) |
| 0.2 |
1.9 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.2 |
0.6 |
GO:0038162 |
erythropoietin-mediated signaling pathway(GO:0038162) mast cell proliferation(GO:0070662) |
| 0.2 |
0.8 |
GO:0009956 |
radial pattern formation(GO:0009956) |
| 0.2 |
1.0 |
GO:1904398 |
positive regulation of neuromuscular junction development(GO:1904398) |
| 0.2 |
0.2 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.2 |
1.4 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.2 |
0.8 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.2 |
2.5 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.2 |
0.6 |
GO:0072106 |
regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
| 0.2 |
0.8 |
GO:0043006 |
activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.2 |
0.7 |
GO:0070460 |
thyroid-stimulating hormone secretion(GO:0070460) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 0.2 |
1.9 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.2 |
2.0 |
GO:0003406 |
retinal pigment epithelium development(GO:0003406) |
| 0.1 |
1.0 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.1 |
0.9 |
GO:0002439 |
chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.1 |
0.8 |
GO:0051563 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) cellular response to norepinephrine stimulus(GO:0071874) |
| 0.1 |
0.5 |
GO:0048377 |
tricuspid valve morphogenesis(GO:0003186) lateral mesodermal cell differentiation(GO:0048371) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) |
| 0.1 |
0.9 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) post-embryonic eye morphogenesis(GO:0048050) |
| 0.1 |
0.6 |
GO:0061034 |
olfactory bulb mitral cell layer development(GO:0061034) |
| 0.1 |
1.0 |
GO:0048014 |
Tie signaling pathway(GO:0048014) |
| 0.1 |
0.4 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.1 |
0.3 |
GO:0060827 |
regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 0.1 |
1.1 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.1 |
0.4 |
GO:0044691 |
tooth eruption(GO:0044691) |
| 0.1 |
2.2 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.1 |
0.3 |
GO:0019089 |
negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010768) transmission of virus(GO:0019089) dissemination or transmission of symbiont from host(GO:0044007) dissemination or transmission of organism from other organism involved in symbiotic interaction(GO:0051821) |
| 0.1 |
0.5 |
GO:0071934 |
thiamine transmembrane transport(GO:0071934) |
| 0.1 |
0.6 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.1 |
0.3 |
GO:0061033 |
secretion by lung epithelial cell involved in lung growth(GO:0061033) |
| 0.1 |
0.3 |
GO:0035509 |
negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.1 |
0.4 |
GO:1901350 |
cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.1 |
0.7 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 0.1 |
0.3 |
GO:0061114 |
hepatocyte cell migration(GO:0002194) otic placode formation(GO:0043049) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
| 0.1 |
1.4 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.1 |
0.5 |
GO:0060979 |
vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 0.1 |
1.2 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.1 |
2.3 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.1 |
0.3 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 0.1 |
1.0 |
GO:0003344 |
pericardium morphogenesis(GO:0003344) |
| 0.1 |
0.9 |
GO:1903142 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.1 |
0.2 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.1 |
0.2 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.1 |
0.3 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.1 |
0.8 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.1 |
1.4 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.1 |
0.2 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.1 |
1.0 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.1 |
0.5 |
GO:0001705 |
ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.1 |
0.5 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.1 |
2.1 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.1 |
0.6 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.1 |
0.3 |
GO:0061026 |
cardiac muscle tissue regeneration(GO:0061026) |
| 0.1 |
0.3 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.1 |
0.6 |
GO:0086024 |
adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.1 |
0.4 |
GO:1903288 |
positive regulation of potassium ion import(GO:1903288) |
| 0.1 |
0.2 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.1 |
0.6 |
GO:0000101 |
sulfur amino acid transport(GO:0000101) |
| 0.0 |
0.3 |
GO:1903788 |
mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.0 |
0.4 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.0 |
1.2 |
GO:0032354 |
response to follicle-stimulating hormone(GO:0032354) |
| 0.0 |
0.2 |
GO:1901254 |
modulation by host of viral RNA genome replication(GO:0044830) positive regulation of intracellular transport of viral material(GO:1901254) |
| 0.0 |
1.1 |
GO:0002089 |
lens morphogenesis in camera-type eye(GO:0002089) |
| 0.0 |
0.2 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.0 |
0.1 |
GO:1904247 |
positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.0 |
0.2 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.0 |
0.1 |
GO:0072720 |
response to dithiothreitol(GO:0072720) |
| 0.0 |
0.2 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.0 |
0.6 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.0 |
1.2 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.0 |
0.1 |
GO:0002025 |
vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
| 0.0 |
0.8 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.0 |
0.3 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.0 |
0.4 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.0 |
0.4 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 0.0 |
0.4 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.0 |
0.8 |
GO:0061162 |
establishment of monopolar cell polarity(GO:0061162) |
| 0.0 |
0.1 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 0.0 |
0.3 |
GO:0070649 |
formin-nucleated actin cable assembly(GO:0070649) |
| 0.0 |
0.1 |
GO:0070602 |
regulation of centromeric sister chromatid cohesion(GO:0070602) |
| 0.0 |
0.8 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.0 |
0.4 |
GO:2000576 |
positive regulation of microtubule motor activity(GO:2000576) |
| 0.0 |
0.7 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.0 |
0.2 |
GO:0071879 |
positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
| 0.0 |
0.9 |
GO:0035641 |
locomotory exploration behavior(GO:0035641) |
| 0.0 |
0.3 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.0 |
2.7 |
GO:0035987 |
endodermal cell differentiation(GO:0035987) |
| 0.0 |
0.2 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.0 |
0.1 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.0 |
0.3 |
GO:0035166 |
post-embryonic hemopoiesis(GO:0035166) |
| 0.0 |
0.3 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.0 |
0.2 |
GO:0051414 |
response to cortisol(GO:0051414) |
| 0.0 |
0.2 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.0 |
1.4 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.0 |
0.5 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.0 |
0.2 |
GO:1900827 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.0 |
0.2 |
GO:0030241 |
skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.0 |
0.3 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.0 |
0.1 |
GO:0046167 |
glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.0 |
0.3 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.0 |
0.2 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.0 |
0.5 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.0 |
1.9 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.0 |
0.6 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.0 |
0.5 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.0 |
0.1 |
GO:0044313 |
protein K6-linked deubiquitination(GO:0044313) protein K27-linked deubiquitination(GO:1990167) |
| 0.0 |
0.3 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.0 |
0.2 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.0 |
0.2 |
GO:0060486 |
Clara cell differentiation(GO:0060486) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.0 |
0.7 |
GO:0001573 |
ganglioside metabolic process(GO:0001573) |
| 0.0 |
0.1 |
GO:0061152 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.0 |
0.6 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.0 |
0.1 |
GO:0015961 |
diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.0 |
0.5 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.0 |
0.4 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.0 |
1.4 |
GO:0090102 |
cochlea development(GO:0090102) |
| 0.0 |
0.1 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.0 |
0.1 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.0 |
0.3 |
GO:0032968 |
positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.0 |
0.5 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.0 |
0.4 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 |
0.4 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.0 |
0.6 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.0 |
0.1 |
GO:1902731 |
negative regulation of chondrocyte proliferation(GO:1902731) |
| 0.0 |
0.1 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.0 |
0.6 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.0 |
0.0 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.0 |
0.1 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.0 |
0.2 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.0 |
0.8 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.0 |
0.1 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.0 |
0.4 |
GO:0035728 |
response to hepatocyte growth factor(GO:0035728) |
| 0.0 |
0.1 |
GO:0033504 |
floor plate development(GO:0033504) |
| 0.0 |
0.3 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.0 |
0.2 |
GO:0060795 |
cell fate commitment involved in formation of primary germ layer(GO:0060795) |
| 0.0 |
0.2 |
GO:0014894 |
response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.0 |
0.4 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.0 |
0.5 |
GO:0007026 |
negative regulation of microtubule depolymerization(GO:0007026) |
| 0.0 |
0.3 |
GO:1902284 |
axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
| 0.0 |
1.9 |
GO:0048024 |
regulation of mRNA splicing, via spliceosome(GO:0048024) |
| 0.0 |
0.1 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.0 |
0.4 |
GO:0071711 |
basement membrane organization(GO:0071711) |
| 0.0 |
0.2 |
GO:1990573 |
potassium ion import across plasma membrane(GO:1990573) |
| 0.0 |
0.2 |
GO:0072189 |
ureter development(GO:0072189) |
| 0.0 |
0.2 |
GO:0010452 |
histone H3-K36 methylation(GO:0010452) |
| 0.0 |
1.0 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.0 |
0.3 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 |
0.2 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.0 |
0.4 |
GO:0010586 |
miRNA metabolic process(GO:0010586) |
| 0.0 |
1.7 |
GO:0045921 |
positive regulation of exocytosis(GO:0045921) |
| 0.0 |
1.3 |
GO:0045638 |
negative regulation of myeloid cell differentiation(GO:0045638) |
| 0.0 |
0.2 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.0 |
0.1 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.0 |
1.0 |
GO:0007585 |
respiratory gaseous exchange(GO:0007585) |
| 0.0 |
0.1 |
GO:0048664 |
neuron fate determination(GO:0048664) |
